In this episode, we go inside the creation of Xaira Therapeutics — the biotech startup that raised over a billion dollars at launch without a product or clinical data.
Speaking with Vik Bajaj, CEO and co-founder of Foresite Labs (and one of the people behind Xaira’s creation), Surani explores how Xaira’s approach could redefine biotech company building, why it’s different from typical AI hype, and what makes it such a bold bet.
We follow Vik’s journey from academia to Google to Grail, and then into biotech investing with Foresite Labs, uncovering how a unique incubator model led to Xaira’s launch. From the big idea to the billion-dollar financing, we unpack what’s really happening behind the headlines.
Timestamps:
00:00 – Introduction: Why Xaira’s billion-dollar launch matters
01:00 – Vik Bajaj’s journey from academia to Google and Grail
04:00 – Moving from big tech to biotech: lessons and perspective
06:00 – Founding Foresite Labs and its unique model for biotech incubation
08:00 – Why data generation is key in biotech AI
09:00 – Foresite’s approach: building data, tools, and teams from scratch
11:00 – The origins of Xaira: ideation, science, and assembling the team
13:00 – Bringing in David Baker’s advanced protein design technology
16:00 – Early team building and leveraging Grail and Illumina networks
17:00 – Xaira’s $1B+ fundraising: why it happened and what it means
20:00 – Why Xaira needed so much capital up front
21:30 – What separates Xaira from other AI drug discovery companies
22:30 – The ambition to build a foundation model of the cell (GPT for biology)
23:00 – De novo design: creating antibodies from scratch
24:30 – Building products and platforms in parallel — not sequentially
26:00 – Where Xaira is today and Foresite’s ongoing role
27:00 – Vik’s vision for success: timelines and goals for Xaira
28:00 – Reflections: Can Xaira’s model really change how biotech is built?
29:00 – Outro: What to watch next, and how to support the podcast
For any comments, questions, feedback or suggestions you can connect directly with Surani Fernando on LinkedIn or email: [email protected]
Title music composed by: Yrii Semchyshyn (Coma Media)